Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial

Abstract Background Definitive concurrent chemoradiotherapy (dCCRT) is the gold standard for the treatment of locally advanced esophageal squamous cell carcinoma (ESCC). However, the potential benefits of consolidation chemotherapy after dCCRT in patients with esophageal cancer remain debatable. Pro...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	BMC Cancer
المؤلفون الرئيسيون:	Chengcheng Fan, Xu Wang, Xiaoli Zheng, Yanan Sun, Ke Ye, Yue Jiang, Xiao Liu, Wencai Xu, Yang Liu, Yuanyuan Yang, Jinsong Liu, Qiong Jiang, Chunyu He, Xiaoyuan Wu, Xin Nie, Jingwei Zhang, Bo Tan, Wen Wang, Yougai Zhang, Zhuo Feng, Chengliang Yang, Yufei Lu, Hailong Liu, Xijuan Chen, Jing Xu, Fang Liu, Xuefeng Zheng, Jianhua Wang, Shang Wu, Guofu Chen, Yaowen Zhang, Linzhi Jin, Hong Ge
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2024-03-01
الموضوعات:	Esophageal squamous cell carcinoma Consolidation chemotherapy Definitive concurrent chemoradiotherapy
الوصول للمادة أونلاين:	https://doi.org/10.1186/s12885-024-12002-5